Clinical Trials Browser

INDUSTRY × Solid Tumor × ensartinib × Clear all

NCT02959619 2023-08-21

Ensartinib in Non-small Cell Lung Cancer Patients With Positive ALK

Phase 1 Completed

Other solid neoplasmThoracic

Solid Tumor